Perzinfotel (EAA-090) is a drug which acts as a potent NMDA antagonist.[1] It has neuroprotective effects and has been investigated for the treatment of stroke,[2] but lacks analgesic effects.[3] Nevertheless, it shows a good safety profile compared to older drugs, although further development of this drug has been discontinued.[4]
Clinical data | |
---|---|
ATC code |
|
Identifiers | |
| |
CAS Number |
|
PubChem CID |
|
ChemSpider |
|
UNII |
|
KEGG |
|
CompTox Dashboard (EPA) |
|
ECHA InfoCard | 100.222.780 |
Chemical and physical data | |
Formula | C9H13N2O5P |
Molar mass | 260.186 g·mol−1 |
3D model (JSmol) |
|
| |
| |
(what is this?) (verify) |
Prodrugs were developed since the oral bioavailability of perzinfotel is only around 3-5%.[5]